[1]Department of Hematology and Oncology Dongzhimen Hospital Beijing University of Chinese Medicine Beijing 100700 China;
[2]HLA et Medicine Batiment Bazin Saint-Louis Hospital Paris 75010 France;
[3]Department of Oncology Dongfang Hospital Beijing University of Chinese Medicine Beijing 100078 China;
[4]Gustave Roussy Villejuif 94805 France;
[5]School of Life Sciences Beijing University of Chinese Medicine Beijing 102488 China;
Immune-related adverse events; Traditional Chinese medicine; Cancer immunotherapy; Immune checkpoint inhibitors;